Pippin JW - Search Results

1

Podocytes in culture: past, present, and future.

Shankland SJ, Pippin JW, Reiser J, Mundel P. Shankland SJ, et al. Among authors: pippin jw. Kidney Int. 2007 Jul;72(1):26-36. doi: 10.1038/sj.ki.5002291. Epub 2007 Apr 25. Kidney Int. 2007. PMID: 17457377 Free article. Review.

2

Modulation of experimental mesangial proliferative nephritis by interferon-gamma.

Johnson RJ, Lombardi D, Eng E, Gordon K, Alpers CE, Pritzl P, Floege J, Young B, Pippin J, Couser WG, et al. Johnson RJ, et al. Kidney Int. 1995 Jan;47(1):62-9. doi: 10.1038/ki.1995.7. Kidney Int. 1995. PMID: 7731171 Free article.

3

Differential expression of transforming growth factor-beta isoforms and receptors in experimental membranous nephropathy.

Shankland SJ, Pippin J, Pichler RH, Gordon KL, Friedman S, Gold LI, Johnson RJ, Couser WG. Shankland SJ, et al. Kidney Int. 1996 Jul;50(1):116-24. doi: 10.1038/ki.1996.294. Kidney Int. 1996. PMID: 8807580 Free article.

4

Transfected CD59 protects mesangial cells from injury induced by antibody and complement.

Nangaku M, Meek RL, Pippin J, Gordon KL, Morgan BP, Johnson RJ, Couser WG. Nangaku M, et al. Kidney Int. 1996 Jul;50(1):257-66. doi: 10.1038/ki.1996.310. Kidney Int. 1996. PMID: 8807596 Free article.

5

Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis.

Brandt J, Pippin J, Schulze M, Hänsch GM, Alpers CE, Johnson RJ, Gordon K, Couser WG. Brandt J, et al. Kidney Int. 1996 Feb;49(2):335-43. doi: 10.1038/ki.1996.50. Kidney Int. 1996. PMID: 8821815 Free article.

6

Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis.

Shankland SJ, Hugo C, Coats SR, Nangaku M, Pichler RH, Gordon KL, Pippin J, Roberts JM, Couser WG, Johnson RJ. Shankland SJ, et al. Kidney Int. 1996 Oct;50(4):1230-9. doi: 10.1038/ki.1996.432. Kidney Int. 1996. PMID: 8887282 Free article.

7

Beneficial effects of systemic immunoglobulin in experimental membranous nephropathy.

Nangaku M, Pippin J, Richardson CA, Schulze M, Young BA, Alpers CE, Gordon KL, Johnson RJ, Couser WG. Nangaku M, et al. Kidney Int. 1996 Dec;50(6):2054-62. doi: 10.1038/ki.1996.529. Kidney Int. 1996. PMID: 8943490 Free article.

8

Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kip1.

Shankland SJ, Pippin J, Flanagan M, Coats SR, Nangaku M, Gordon KL, Roberts JM, Couser WG, Johnson RJ. Shankland SJ, et al. Kidney Int. 1997 Apr;51(4):1088-99. doi: 10.1038/ki.1997.151. Kidney Int. 1997. PMID: 9083274 Free article.

9

A new model of renal microvascular endothelial injury.

Nangaku M, Alpers CE, Pippin J, Shankland SJ, Adler S, Kurokawa K, Couser WG, Johnson RJ. Nangaku M, et al. Kidney Int. 1997 Jul;52(1):182-94. doi: 10.1038/ki.1997.318. Kidney Int. 1997. PMID: 9211361 Free article.

10

Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo.

Shankland SJ, Floege J, Thomas SE, Nangaku M, Hugo C, Pippin J, Henne K, Hockenberry DM, Johnson RJ, Couser WG. Shankland SJ, et al. Kidney Int. 1997 Aug;52(2):404-13. doi: 10.1038/ki.1997.347. Kidney Int. 1997. PMID: 9263996 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters